Edwards Lifesciences Corp (NYSE:EW)
$ 90.34 0.56 (0.62%) Market Cap: 54.44 Bil Enterprise Value: 53.10 Bil PE Ratio: 38.94 PB Ratio: 7.64 GF Score: 98/100

Edwards Lifesciences Corp at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 07:00PM GMT
Release Date Price: $77.8 (+0.24%)
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. I'm Robbie Marcus, the med tech analyst here at JPMorgan.

I'm very happy to introduce our next speaker, Chairman and CEO of Edwards, Mike Mussallem.

Michael A. Mussallem
Edwards Lifesciences Corporation - Chairman & CEO

Thanks, Robbie. All right. Thanks, Robbie. Thanks all of you for being here, another JPMorgan conference. I hope you enjoy it. We're going to be making some forward-looking statements that have risks associated with that. If you're interested in our risks, they're filed with the SEC on our website, you can take a look. And we also use non-GAAP financial measures to help provide clarity, and those are also available on our website and in our SEC filings.

So when our company was founded, and really spun out 20 years ago now, we did it on the basis of our credo. And our credo talks about several things, things like being a trusted partner, there's much of what we do, we just cannot do alone. But we talked about this multi

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot